INTERPACE BIOSCIENCES, INC. (IDXG)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 20M 40M 60M FY16: 13.1M FY17: 15.9M FY18: 21.9M FY19: 24.2M FY20: 32.4M FY21: 33.1M FY22: 31.8M FY23: 40M FY24: 46.9M FY25: 38.7M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 15M 30M 45M FY16: 6.4M FY17: 8.5M FY18: 11.7M FY19: 8.3M FY20: 10.7M FY21: 18.8M FY22: 18.2M FY23: 25.1M FY24: 29.9M FY25: 24.1M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Income Annual

-27M -18M -9M 0 9M 18M 27M FY16: -6.4M FY17: -6.3M FY18: -12.6M FY19: -26.4M FY20: -26.1M FY21: -6.3M FY22: -3.6M FY23: 4M FY24: 8.1M FY25: 4.1M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-30M -20M -10M 0 10M 20M 30M FY16: -22M FY17: 12.6M FY18: -12.7M FY19: -26.7M FY20: -26.5M FY21: -14.9M FY22: -22M FY23: 2M FY24: 6.7M FY25: 24.6M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 8M 16M 24M FY16: 6.6M FY17: 7.4M FY18: 10.2M FY19: 15.9M FY20: 21.7M FY21: 14.3M FY22: 13.6M FY23: 15M FY24: 17M FY25: 14.6M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-21M -14M -7M 0 7M 14M 21M FY16: -7.6M FY17: -15.3M FY18: -8.7M FY19: -19M FY20: -14M FY21: -8.7M FY22: -7.7M FY23: 3.8M FY24: 4.6M FY25: 5.8M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-21M -14M -7M 0 7M 14M 21M FY15: -20.2M FY17: -15.3M FY18: -9.1M FY19: -19.1M FY20: -15.6M FY21: -9.1M FY22: -8M FY23: 3.3M FY24: 3.8M FY25: 5.5M FY15 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 10M 20M 30M FY16: 1.8M FY17: 15.8M FY18: 2.8M FY19: 3.7M FY20: 4M FY21: 4.1M FY22: 4.2M FY23: 4.4M FY24: 15.7M FY25: 27.7M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-150.00 -100.00 -50.00 0.00 50.00 100.00 150.00 Q3 '13: -1.70 Q4 '13: -0.32 Q1 '14: -0.57 Q2 '14: -0.69 Q3 '14: -0.83 Q4 '15: -87.95 Q1 '16: -90.38 Q2 '16: -91.21 Q3 '16: -95.03 Q4 '16: -120.91 Q1 '17: -117.67 Q2 '17: -117.03 Q3 '17: -113.05 Q4 '17: -7.61 Q1 '18: -8.27 Q2 '18: -7.69 Q3 '20: -8.20 Q4 '20: -7.32 Q1 '21: -5.97 Q2 '21: -5.43 Q3 '21: -4.74 Q4 '21: -3.61 Q1 '22: -3.11 Q2 '22: -3.20 Q3 '22: -5.70 Q4 '22: -5.17 Q1 '23: -4.56 Q2 '23: -3.59 Q3 '23: -0.38 Q4 '23: 0.23 Q1 '24: 0.31 Q2 '24: 0.82 Q3 '24: 1.34 Q4 '24: 1.41 Q1 '25: 1.31 Q2 '25: 0.62 Q3 '25: 0.27 Q4 '25: 0.77 Q1 '26: 0.74 Q2 '26: 0.89 Q3 '14 Q4 '16 Q1 '18 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.